Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News ACADIA Pharmaceuticals Inc ACAD

Healthcare Biotechnology
Acadia Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases. It has a portfolio of commercial stage products, in-development product opportunities, and research programs that are designed to address unmet needs in CNS disorders... see more

Recent & Breaking News (NDAQ:ACAD)

ACADIA Pharmaceuticals to Present at Upcoming Investor Conferences

Business Wire February 24, 2015

ACADIA Pharmaceuticals to Announce Fourth Quarter and Full Year 2014 Financial Results on February 26, 2015

Business Wire February 19, 2015

ACADIA Pharmaceuticals to Present at the 33rd Annual J.P. Morgan Healthcare Conference on January 13, 2015

Business Wire January 6, 2015

ACADIA Pharmaceuticals Presents Caregiver Burden Data at the International Congress of Non-Motor Dysfunctions in Parkinson's Disease and Related Disorders

Business Wire December 8, 2014

ACADIA Pharmaceuticals to Present at Upcoming Investor Conferences

Business Wire November 25, 2014

ACADIA Pharmaceuticals to Present at Jefferies 2014 Global Healthcare Conference on November 20, 2014

Business Wire November 13, 2014

ACADIA Pharmaceuticals Reports Third Quarter 2014 Financial Results and Updates Timing of NUPLAZID(TM) NDA Submission

Business Wire November 10, 2014

ACADIA Pharmaceuticals to Announce Third Quarter 2014 Financial Results on November 10, 2014

Business Wire November 3, 2014

ACADIA Pharmaceuticals Receives FDA Breakthrough Therapy Designation for NUPLAZID(TM) (Pimavanserin) for Parkinson's Disease Psychosis

Business Wire September 2, 2014

ACADIA Pharmaceuticals Announces Trade Name NUPLAZID(TM) for Pimavanserin

Business Wire August 28, 2014

ACADIA Pharmaceuticals Reports Second Quarter 2014 Financial Results

Business Wire August 5, 2014

ACADIA Pharmaceuticals to Announce Second Quarter 2014 Financial Results on August 5, 2014

Business Wire July 29, 2014

ACADIA Pharmaceuticals Announces Appointment of Stephen Davis as Executive Vice President, Chief Financial Officer and Chief Business Officer

Business Wire July 15, 2014

ACADIA Pharmaceuticals to Present at the 9th Annual JMP Securities Healthcare Conference on June 24, 2014

Business Wire June 17, 2014

ACADIA Pharmaceuticals to Present at the Jefferies 2014 Global Healthcare Conference on June 2, 2014

Business Wire May 27, 2014

ACADIA Pharmaceuticals Reports First Quarter 2014 Financial Results

Business Wire May 6, 2014

ACADIA Pharmaceuticals to Present at Upcoming Investor Conferences

Business Wire May 1, 2014

ACADIA Pharmaceuticals to Announce First Quarter 2014 Financial Results on May 6, 2014

Business Wire April 29, 2014

ACADIA Pharmaceuticals to Present at the 13th Annual Needham Healthcare Conference on April 8, 2014

Business Wire April 1, 2014

From Lab Bench to Bedside: David Lowe Brings Common Sense to Neuroscience Investing

Equities.com March 31, 2014